Search research articles
Contact Us
Filters
Showing results (41-50 of 284) with videos related to
Page
of 29
Sort By:
Heliyon
|
September 12, 2024
First line therapy in stage IV BRAF mutated colorectal cancer
Fausto Petrelli, Maria Antista, Lorenzo Dottorini, et al.
Clinical Colorectal Cancer
|
February 1, 2022
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival
Davide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2020
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer
Chiara Cremolini, Carlotta Antoniotti, Alexander Stein, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 28, 2010
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
Fotios Loupakis, Emilio Bria, Vanja Vaccaro, et al.
Cancer
|
October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategies
Fotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.
The Journal of Molecular Diagnostics : JMD
|
March 17, 2020
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation
Riccardo Giannini, Gemma Zucchelli, Mirella Giordano, et al.
Updates in Surgery
|
May 9, 2023
Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial)
Federico Coccolini, Alessio Mazzoni, Camilla Cremonini, et al.
La Radiologia Medica
|
November 18, 2025
Attenuation-based estimation of myocardial extracellular volume from ECG-ungated whole-body CT examinations as an early biomarker of chemotherapy-induced cardiotoxicity: preliminary findings
Giovanni Donato Aquaro, Lorenzo Faggioni, Roberto Francischello, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 3, 2023
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
Stefania Crucitta, Martina Ruglioni, Claudia Novi, et al.
Investigational New Drugs
|
March 1, 2018
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients
Teresa Di Desidero, Paola Orlandi, Anna Fioravanti, et al.
Page
of 29
Search research articles
Search
Showing results (41-50 of 284) with videos related to
Sort By:
Page
of 29
Heliyon
|
September 12, 2024
First line therapy in stage IV BRAF mutated colorectal cancer
Fausto Petrelli, Maria Antista, Lorenzo Dottorini, et al.
Clinical Colorectal Cancer
|
February 1, 2022
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival
Davide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2020
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer
Chiara Cremolini, Carlotta Antoniotti, Alexander Stein, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 28, 2010
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
Fotios Loupakis, Emilio Bria, Vanja Vaccaro, et al.
Cancer
|
October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategies
Fotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.
The Journal of Molecular Diagnostics : JMD
|
March 17, 2020
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation
Riccardo Giannini, Gemma Zucchelli, Mirella Giordano, et al.
Updates in Surgery
|
May 9, 2023
Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial)
Federico Coccolini, Alessio Mazzoni, Camilla Cremonini, et al.
La Radiologia Medica
|
November 18, 2025
Attenuation-based estimation of myocardial extracellular volume from ECG-ungated whole-body CT examinations as an early biomarker of chemotherapy-induced cardiotoxicity: preliminary findings
Giovanni Donato Aquaro, Lorenzo Faggioni, Roberto Francischello, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 3, 2023
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
Stefania Crucitta, Martina Ruglioni, Claudia Novi, et al.
Investigational New Drugs
|
March 1, 2018
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients
Teresa Di Desidero, Paola Orlandi, Anna Fioravanti, et al.
Page
of 29